Application 213734
- Type
- ANDA
- Sponsor
- AMNEAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METYROSINE | METYROSINE | CAPSULE;ORAL | 250MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60219-1621 | metyrosine | metyrosine | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 60219-1621 | metyrosine | metyrosine | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1621 | metyrosine | metyrosine | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1621 | metyrosine | metyrosine | Amneal Pharmaceuticals NY LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64391 | ORIG | 2020-08-24 |